Cryogenic OGS

Which are the latest news on Cryogenic OGS?

Why is Cryogenic OGS Ltd falling/rising?

As of 05-Sep, Cryogenic OGS Ltd's stock price is at 357.70, down 2.0% and underperforming its sector. Despite increased investor participation, the stock shows short-term weakness and negative sentiment due to recent declines.

As of 05-Sep, Cryogenic OGS Ltd's stock price is currently at 357.70, reflecting a decrease of 7.3 points or 2.0%. The stock has been underperforming, having lost 3.35% over the last two days, which contributes to its current decline. Additionally, today's performance shows that it has underperformed its sector by 1.47%. <BR><BR>In terms of recent trends, the stock has experienced a narrow trading range of Rs 0.7 and touched an intraday low of Rs 357.7. While the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, indicating a short-term weakness. <BR><BR>Despite these declines, there has been a rise in investor participation, with delivery volume increasing by 1.45% compared to the 5-day average. However, the overall sentiment appears to be negative given the recent consecutive falls and the stock's underperformance relative to the sector.

What does Cryogenic OGS do?

Cryogenic OGS Ltd is a micro-cap company in the industrial products sector, previously known as Mangukia Steel Private Limited, with no recent sales or profit data available. As of now, it has a market cap of INR 518 Cr, a P/E ratio of 55.00, and a return on equity of 16.92%.

Overview:<BR>Cryogenic OGS Ltd operates in the industrial products sector and is classified as a micro-cap company.<BR><BR>History:<BR>The company was originally incorporated in 1997 under the name Mangukia Steel Private Limited. It underwent several name changes, becoming Cryogenic Liquide Private Limited in 2011 and later Cryogenic OGS Private Limited in October 2023. There is no sales or profit data available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 518 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 55.00<BR>Industry P/E: 41<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -0.45<BR>Return on Equity: 16.92%<BR>Price-to-Book: 9.49<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the Cryogenic OGS?

Peers of Cryogenic OGS include Borosil Scientific, GRP, Sejal Glass, JTL Defence, L. T. Elevator, Parmeshwar Metal, and Patil Automation. Cryogenic OGS leads with a 1-year return of 219.92%, while Borosil Scientific has the lowest at -10.36%.

Peers: The peers of Cryogenic OGS are Borosil Scienti., GRP, Sejal Glass, JTL Defence, L. T. Elevator, Parmeshwar Metal, and Patil Automation.<BR><BR>Quality Snapshot: Excellent management risk is observed at Parmeshwar Metal, while Good management risk is found at L. T. Elevator and Patil Automation, and the rest have Below Average management risk. Growth is Excellent at Sejal Glass and Parmeshwar Metal, while Good growth is noted at L. T. Elevator, Average growth at Cryogenic OGS, and the rest have Below Average growth. Excellent capital structure is seen at Borosil Scienti., L. T. Elevator, Cryogenic OGS, Parmeshwar Metal, and Patil Automation, while Below Average capital structure is noted at GRP and Sejal Glass, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Cryogenic OGS at 219.92%, while the lowest is Borosil Scienti. at -10.36%. Cryogenic OGS's 1-year return significantly outperforms all peers. Additionally, Patil Automation has a six-month return of 0.00%, indicating no growth.

How big is Cryogenic OGS?

As of 14th August, Cryogenic OGS Ltd has a market capitalization of 498.00 Cr, classified as a Micro Cap, with no valid financial data available for the latest four quarters. The latest balance sheet shows Shareholder's Funds of 54.65 Cr and Total Assets of 66.43 Cr as of March 2026.

As of 14th August, <BR><BR>Market Cap: Cryogenic OGS Ltd has a market capitalization of 498.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2026, with Shareholder's Funds amounting to 54.65 Cr and Total Assets of 66.43 Cr.

Is Cryogenic OGS overvalued or undervalued?

As of October 17, 2025, Cryogenic OGS is considered very expensive and overvalued with a PE ratio of 42.91, despite recent strong stock returns of 17.08% and 22.98% over the past week and month, respectively, making it an unfavorable investment at its current price of 183.00.

As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its key financial ratios, including a PE ratio of 42.91, an EV to EBITDA ratio of 29.49, and a Price to Book Value of 5.23. <BR><BR>When compared to its peers, Cryogenic OGS stands out with a higher PE ratio than Thermax at 55.98 and BEML Ltd at 61.47, both of which are also classified as very expensive. The company has shown strong returns over the past week and month, outperforming the Sensex with a stock return of 17.08% and 22.98%, respectively. However, despite these short-term gains, the overall valuation suggests that Cryogenic OGS is not a favorable investment at its current price of 183.00.

How has been the historical performance of Cryogenic OGS?

Cryogenic OGS has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 22.02 Cr in Mar'23 to 32.90 Cr in Mar'25, and profit after tax rising from 4.08 Cr to 6.09 Cr. The company maintains a healthy balance sheet with no long-term borrowings and improved cash flow.

Answer:<BR>The historical performance of Cryogenic OGS shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Cryogenic OGS has demonstrated a consistent increase in net sales, rising from 22.02 Cr in Mar'23 to 24.25 Cr in Mar'24, and further to 32.90 Cr in Mar'25. Total operating income mirrored this trend, reaching 32.90 Cr in Mar'25. However, raw material costs also increased significantly, from 11.70 Cr in Mar'23 to 21.26 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 16.37 Cr in Mar'23 to 24.94 Cr in Mar'25, yet the operating profit (PBDIT) improved from 6.34 Cr in Mar'23 to 8.85 Cr in Mar'25. Profit before tax also saw an upward trajectory, increasing from 5.48 Cr in Mar'23 to 8.27 Cr in Mar'25, while profit after tax rose from 4.08 Cr to 6.09 Cr in the same period. The earnings per share (EPS) increased from 3.89 in Mar'23 to 5.8 in Mar'25. On the balance sheet, total assets grew from 23.95 Cr in Mar'23 to 33.73 Cr in Mar'25, with total liabilities also increasing from 23.95 Cr to 33.73 Cr. The company maintained no long-term borrowings, and cash and cash equivalents rose from 8.10 Cr in Mar'23 to 11.07 Cr in Mar'25, indicating a positive cash flow position. Overall, Cryogenic OGS has shown robust growth in sales and profitability, alongside a healthy balance sheet.